Alvotech and Dr. Reddy’s Enter into collaboration to co-develop biosimilar candidate to Keytruda® (pembrolizumab).

Amodei instead called for the White House and Congress to work together on a transparency standard for AI companies at a ...

Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt ...

A round of thanks is clearly owed to retail investors, who have been faithfully buying the dip as institutional investors and hedge funds shied away. Not everyone is enthusiastic, though.